ZTE Corporation, a leading global provider of telecommunications equipment and network solutions, launched the world’s fastest HSUPA data card at the 3GSM World Congress 2007 in Barcelona, Spain.
World Data Center(WDC)for Seismology,Beijing has developed for 20 years in China until this year.The sustained and stable data sharing service system has already taken shape.This article gives an overview of the const...World Data Center(WDC)for Seismology,Beijing has developed for 20 years in China until this year.The sustained and stable data sharing service system has already taken shape.This article gives an overview of the construction and development of WDC for Seismology,Beijing.It outlines the history,facilities and technical specifications of the center.It also illustrates the data service,the website,and gives a brief description of the perspective.展开更多
Affiliationunit: The CAS Bureau for Coordinated Development Between Nature & Society The WDC, standing for the World Data Center,is one of the subordinate bodies under the International Council of Scientific Union...Affiliationunit: The CAS Bureau for Coordinated Development Between Nature & Society The WDC, standing for the World Data Center,is one of the subordinate bodies under the International Council of Scientific Unions (ICSU) for the benefit of the international community of scientists and provides a global mechanism of data management for all disciplinary developments related to the Earth, environment and Sun. The WDC is in charge of the collection, archiving, distribution and exchange of these data, which cover a variety of time scales ranging from seconds to millennia and con tain baseline information for scientific research, in line with procedures and standards展开更多
24 September 2013, Shenzhen--ZTE today announced the release of the BigMatrix 9900 series of data center switches, the world＇ s largest-capacity data center switches. The BigMatrix 9900 product family comprises data...24 September 2013, Shenzhen--ZTE today announced the release of the BigMatrix 9900 series of data center switches, the world＇ s largest-capacity data center switches. The BigMatrix 9900 product family comprises data switches with the largest capacity in the world. The switches are designed large cloud computing and big data scenarios and allow for higher-density deployment in data centers. Each single slot can support up to 144 10G ports, 36 40G ports, or 12 IOOG ports. The Big Matrix 9900 series comprises four switch models-9916, 9912, 9908, and 9904-each of which supports a maximum switching capacity of 84.48 Tbps.展开更多
Objective:To explore the general characteristics,traditional Chinese medicine(TCM)syndromes and medication of patients with rectal cancer in China.Methods:The clinical data of inpatients with rectal cancer from the in...Objective:To explore the general characteristics,traditional Chinese medicine(TCM)syndromes and medication of patients with rectal cancer in China.Methods:The clinical data of inpatients with rectal cancer from the information system of 17 tertiary A‑level traditional Chinese medicine hospitals in China were collected.After data standardization,descriptive analysis was performed on the general information,syndrome distribution and medication characteristics of the included patients,and association rule analysis was performed on the drug usage.Results:A total of 15424 hospitalized patients with rectal cancer were included.The ratio of male to female patients was 1.6:1,the average age was 60.87 years old,and the age was mainly in the range of 50 to 79 years old.Among the 12146 patients with rectal cancer,the top 5 TCM syndromes were Qi and Yin deficiency syndrome(25%),phlegm and blood stasis syndrome(19%),spleen deficiency syndrome(14%),Qi stagnation and blood stasis syndrome(7%)and Qi and blood deficiency syndrome(6%).After excluding the anti‑tumor western medicine recommended by the guidelines,adrenal corticosteroids(43.55%),antibiotics(42.94%)and immunomodulatory drugs(42.66%)ranked the top three in the frequency of western medicine use.Dexamethasone(38.15%),metoclopramide tablets(20.51%)and furosemide injection(19.71%)were the three most commonly used western medicines.Among the three western medicines combined,cimetidine,granisetron hydrochloride dextrose injection+dexamethasone were the most common(support 8.23%,confidence 96.4%,and improvement 2.48%).Heat‑clearing and detoxifying agents(53.72%),Yiqi‑fuzheng agents(49.76%)and blood‑activating and stasis‑removing agents(15.68%)ranked the top 3 in the frequency of use of traditional Chinese medicine.Shenqi Fuzheng injection,Shenqi Fuzheng injection(21.59%),Compound Kushen injection(17.52%)and Aidi injection(11.96%)were the three most commonly used Chinese patent medicines.Conclusion:The main syndromes of patients with rectal cancer may be Qi and Yin deficiency syndrome,phlegm and blood stasis syndrome,and spleen deficiency syndrome,etc.The treatment needs to focus on the supplementation of vital essence,combination of dredging and tonifying method,and the integration of traditional Chinese and western medicine.展开更多
目的基于真实世界数据,挖掘各年龄段儿童万古霉素的药物不良反应(adverse drug reaction,ADR),并探索其影响因素。方法采用回顾性队列研究方法,选取笔者所在医院2010年1月—2025年5月使用万古霉素的儿童住院患者(1334例次)。参考美国食...目的基于真实世界数据,挖掘各年龄段儿童万古霉素的药物不良反应(adverse drug reaction,ADR),并探索其影响因素。方法采用回顾性队列研究方法,选取笔者所在医院2010年1月—2025年5月使用万古霉素的儿童住院患者(1334例次)。参考美国食品药品监督管理局不良事件报告系统数据库、福建省及厦门市ADR监测情况,采用中国医院药物警戒系统筛选其中发生严重ADR/ADR的例次,比较新生儿、婴幼儿和儿童人群已知的以及新的严重ADR/ADR发生情况,并采用Logistic回归模型分析影响因素。结果发生率较高的ADR为血液及淋巴系统疾病,严重ADR发生率最高的为血红蛋白降低(123例次,9.22%),且新生儿发生率显著高于婴幼儿和儿童。新的ADR包括血压下降、弥散性血管内凝血、淋巴细胞升高、淋巴结肿大、高钾血症、低白蛋白血症、心动过速等。针对发生率前5位组间存在差异的ADR(嗜酸性粒细胞增多、红细胞减少、血红蛋白降低、γ-谷氨酰转肽酶升高和心动过速)进行影响因素分析,结果显示:超说明书给药增加嗜酸性粒细胞增多的风险(OR=1.807,95%CI:1.128~2.896),合并用药数每增加1个,发生嗜酸性粒细胞增多、红细胞减少、γ-谷氨酰转肽酶升高和心动过速的风险分别增加1.7%、2.5%、2.4%和4.4%。结论在儿童人群(特别是新生儿)中使用万古霉素应注意血常规、肝功能和心电监测。建议进行分层风险管理,通过临床药师参与用药指导,结合血药浓度监测进行早期预警,并优化合并用药情况,提升万古霉素的用药安全。展开更多
文摘ZTE Corporation, a leading global provider of telecommunications equipment and network solutions, launched the world’s fastest HSUPA data card at the 3GSM World Congress 2007 in Barcelona, Spain.
文摘World Data Center(WDC)for Seismology,Beijing has developed for 20 years in China until this year.The sustained and stable data sharing service system has already taken shape.This article gives an overview of the construction and development of WDC for Seismology,Beijing.It outlines the history,facilities and technical specifications of the center.It also illustrates the data service,the website,and gives a brief description of the perspective.
文摘Affiliationunit: The CAS Bureau for Coordinated Development Between Nature & Society The WDC, standing for the World Data Center,is one of the subordinate bodies under the International Council of Scientific Unions (ICSU) for the benefit of the international community of scientists and provides a global mechanism of data management for all disciplinary developments related to the Earth, environment and Sun. The WDC is in charge of the collection, archiving, distribution and exchange of these data, which cover a variety of time scales ranging from seconds to millennia and con tain baseline information for scientific research, in line with procedures and standards
文摘24 September 2013, Shenzhen--ZTE today announced the release of the BigMatrix 9900 series of data center switches, the world＇ s largest-capacity data center switches. The BigMatrix 9900 product family comprises data switches with the largest capacity in the world. The switches are designed large cloud computing and big data scenarios and allow for higher-density deployment in data centers. Each single slot can support up to 144 10G ports, 36 40G ports, or 12 IOOG ports. The Big Matrix 9900 series comprises four switch models-9916, 9912, 9908, and 9904-each of which supports a maximum switching capacity of 84.48 Tbps.
基金supported by the self‑selected project of China Academy of Chinese Medical Sciences(No.Z0472)。
文摘Objective:To explore the general characteristics,traditional Chinese medicine(TCM)syndromes and medication of patients with rectal cancer in China.Methods:The clinical data of inpatients with rectal cancer from the information system of 17 tertiary A‑level traditional Chinese medicine hospitals in China were collected.After data standardization,descriptive analysis was performed on the general information,syndrome distribution and medication characteristics of the included patients,and association rule analysis was performed on the drug usage.Results:A total of 15424 hospitalized patients with rectal cancer were included.The ratio of male to female patients was 1.6:1,the average age was 60.87 years old,and the age was mainly in the range of 50 to 79 years old.Among the 12146 patients with rectal cancer,the top 5 TCM syndromes were Qi and Yin deficiency syndrome(25%),phlegm and blood stasis syndrome(19%),spleen deficiency syndrome(14%),Qi stagnation and blood stasis syndrome(7%)and Qi and blood deficiency syndrome(6%).After excluding the anti‑tumor western medicine recommended by the guidelines,adrenal corticosteroids(43.55%),antibiotics(42.94%)and immunomodulatory drugs(42.66%)ranked the top three in the frequency of western medicine use.Dexamethasone(38.15%),metoclopramide tablets(20.51%)and furosemide injection(19.71%)were the three most commonly used western medicines.Among the three western medicines combined,cimetidine,granisetron hydrochloride dextrose injection+dexamethasone were the most common(support 8.23%,confidence 96.4%,and improvement 2.48%).Heat‑clearing and detoxifying agents(53.72%),Yiqi‑fuzheng agents(49.76%)and blood‑activating and stasis‑removing agents(15.68%)ranked the top 3 in the frequency of use of traditional Chinese medicine.Shenqi Fuzheng injection,Shenqi Fuzheng injection(21.59%),Compound Kushen injection(17.52%)and Aidi injection(11.96%)were the three most commonly used Chinese patent medicines.Conclusion:The main syndromes of patients with rectal cancer may be Qi and Yin deficiency syndrome,phlegm and blood stasis syndrome,and spleen deficiency syndrome,etc.The treatment needs to focus on the supplementation of vital essence,combination of dredging and tonifying method,and the integration of traditional Chinese and western medicine.
文摘目的基于真实世界数据,挖掘各年龄段儿童万古霉素的药物不良反应(adverse drug reaction,ADR),并探索其影响因素。方法采用回顾性队列研究方法,选取笔者所在医院2010年1月—2025年5月使用万古霉素的儿童住院患者(1334例次)。参考美国食品药品监督管理局不良事件报告系统数据库、福建省及厦门市ADR监测情况,采用中国医院药物警戒系统筛选其中发生严重ADR/ADR的例次,比较新生儿、婴幼儿和儿童人群已知的以及新的严重ADR/ADR发生情况,并采用Logistic回归模型分析影响因素。结果发生率较高的ADR为血液及淋巴系统疾病,严重ADR发生率最高的为血红蛋白降低(123例次,9.22%),且新生儿发生率显著高于婴幼儿和儿童。新的ADR包括血压下降、弥散性血管内凝血、淋巴细胞升高、淋巴结肿大、高钾血症、低白蛋白血症、心动过速等。针对发生率前5位组间存在差异的ADR(嗜酸性粒细胞增多、红细胞减少、血红蛋白降低、γ-谷氨酰转肽酶升高和心动过速)进行影响因素分析,结果显示:超说明书给药增加嗜酸性粒细胞增多的风险(OR=1.807,95%CI:1.128~2.896),合并用药数每增加1个,发生嗜酸性粒细胞增多、红细胞减少、γ-谷氨酰转肽酶升高和心动过速的风险分别增加1.7%、2.5%、2.4%和4.4%。结论在儿童人群(特别是新生儿)中使用万古霉素应注意血常规、肝功能和心电监测。建议进行分层风险管理,通过临床药师参与用药指导,结合血药浓度监测进行早期预警,并优化合并用药情况,提升万古霉素的用药安全。
